<DOC>
	<DOCNO>NCT01385527</DOCNO>
	<brief_summary>The purpose study evaluate whether participation Internet-based intervention help improve atopic dermatitis treatment outcome .</brief_summary>
	<brief_title>Pediatric Atopic Dermatitis ( AD ) Internet Survey</brief_title>
	<detailed_description />
	<mesh_term>Dermatitis</mesh_term>
	<mesh_term>Dermatitis , Atopic</mesh_term>
	<mesh_term>Eczema</mesh_term>
	<mesh_term>Triamcinolone hexacetonide</mesh_term>
	<mesh_term>Triamcinolone</mesh_term>
	<mesh_term>Triamcinolone Acetonide</mesh_term>
	<mesh_term>Triamcinolone diacetate</mesh_term>
	<criteria>Any child age 2 8 diagnosis atopic dermatitis confirm dermatologist , together child 's parent/guardian . Written consent must give parent/guardian . Child le 2 great 8 year age . Known allergy sensitivity topical triamcinolone child . Inability complete studyrelated visit , inability complete Internet survey due inadequate Internet access . Introduction prescription medication , topical systemic , atopic dermatitis participate study . Subjects systemic antiinflammatory treatment atopic dermatitis must stable dose least 3 month prior enrollment .</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>8 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>